Class information for:
Level 2: ALPHAVBETA3 INTEGRIN//CILENGITIDE//DISCOIDIN DOMAIN RECEPTOR

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
2970 2159 45.9 90%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)



ID, lev.
above
Publications Label for level above
299 36420 CD44//HYALURONAN//INTEGRIN

Classes in level below (level 1)



ID, lev. below Publications Label for level below
5224 1586 ALPHAVBETA3 INTEGRIN//CILENGITIDE//ALPHAVBETA3
22326 329 DISCOIDIN DOMAIN RECEPTOR//DISCOIDIN DOMAIN RECEPTOR 2//DISCOIDIN DOMAIN RECEPTORS
28208 173 NEPHRONECTIN//VLA 1//ALPHA 8 INTEGRIN
34453 71 ISTHMIN//METEORIN//NEURENSIN 2

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ALPHAVBETA3 INTEGRIN Author keyword 74 42% 6% 137
2 CILENGITIDE Author keyword 73 80% 2% 45
3 DISCOIDIN DOMAIN RECEPTOR Author keyword 47 84% 1% 26
4 DISCOIDIN DOMAIN RECEPTOR 2 Author keyword 35 86% 1% 18
5 ALPHAVBETA3 Author keyword 30 40% 3% 58
6 MED ISOTOPES Address 24 44% 2% 40
7 DISCOIDIN DOMAIN RECEPTORS Author keyword 23 100% 0% 10
8 DDR2 Author keyword 23 62% 1% 24
9 INTETUMUMAB Author keyword 21 90% 0% 9
10 DDR1 Author keyword 18 58% 1% 21

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 ALPHAVBETA3 INTEGRIN 74 42% 6% 137 Search ALPHAVBETA3+INTEGRIN Search ALPHAVBETA3+INTEGRIN
2 CILENGITIDE 73 80% 2% 45 Search CILENGITIDE Search CILENGITIDE
3 DISCOIDIN DOMAIN RECEPTOR 47 84% 1% 26 Search DISCOIDIN+DOMAIN+RECEPTOR Search DISCOIDIN+DOMAIN+RECEPTOR
4 DISCOIDIN DOMAIN RECEPTOR 2 35 86% 1% 18 Search DISCOIDIN+DOMAIN+RECEPTOR+2 Search DISCOIDIN+DOMAIN+RECEPTOR+2
5 ALPHAVBETA3 30 40% 3% 58 Search ALPHAVBETA3 Search ALPHAVBETA3
6 DISCOIDIN DOMAIN RECEPTORS 23 100% 0% 10 Search DISCOIDIN+DOMAIN+RECEPTORS Search DISCOIDIN+DOMAIN+RECEPTORS
7 DDR2 23 62% 1% 24 Search DDR2 Search DDR2
8 INTETUMUMAB 21 90% 0% 9 Search INTETUMUMAB Search INTETUMUMAB
9 DDR1 18 58% 1% 21 Search DDR1 Search DDR1
10 RGD 14 14% 4% 90 Search RGD Search RGD

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ALPHAVBETA3 140 32% 17% 365
2 ALPHAVBETA3 INTEGRIN 82 21% 16% 342
3 CANCER ALPHAV INTEGRIN EXPRESSION 79 85% 2% 41
4 INTEGRIN ALPHAVBETA3 EXPRESSION 61 58% 3% 71
5 DDR1 48 91% 1% 20
6 F 18 GALACTO RGD 47 88% 1% 22
7 GLIOMA INTEGRIN ALPHAVBETA3 EXPRESSION 44 88% 1% 21
8 TYROSINE KINASE DDR1 38 93% 1% 14
9 ALPHAVBETA3 ANTAGONISTS 37 75% 1% 27
10 ALPHA V BETA 3 EXPRESSION 32 85% 1% 17

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Integrins in cancer: biological implications and therapeutic opportunities 2010 811 187 45%
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis 2012 115 95 49%
Discoidin Domain Receptor Functions in Physiological and Pathological Conditions 2014 10 171 81%
Ligands for Mapping alpha(v)beta(3)-Integrin Expression in Vivo 2009 138 73 77%
Radiolabeled Cyclic RGD Peptides as Integrin alpha(v)beta(3)-Targeted Radiotracers: Maximizing Binding Affinity via Bivalency 2009 145 120 72%
Radiolabelled RGD peptides for imaging and therapy 2012 53 71 76%
Integrins as therapeutic targets 2012 87 57 47%
Discoidin Domain Receptors: Unique Receptor Tyrosine Kinases in Collagen-mediated Signaling 2013 29 88 63%
Discoidin domain receptor tyrosine kinases: new players in cancer progression 2012 48 178 74%
Integrins in angiogenesis and lymphangiogenesis 2008 358 139 34%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MED ISOTOPES 24 44% 1.9% 40
2 INTERDIPARTIMENTALE STUDI BIOMOL PLICAZ I 8 100% 0.2% 5
3 ONCOL PLATFORM 6 100% 0.2% 4
4 RADIOL MIPS 6 100% 0.2% 4
5 MOL IMAGING NANOMED 5 18% 1.1% 24
6 INTER PRECLIN DEV MOL IMAGING CISPIM 4 67% 0.2% 4
7 RADIOL BIOX 4 67% 0.2% 4
8 ADHES ANGIOGENESIS GRP 4 75% 0.1% 3
9 EUGENE MARCIA PELBAUM INVAS MOL THER E 3 100% 0.1% 3
10 BONE BIOL OSTEOPOROSIS 3 19% 0.7% 15

Related classes at same level (level 2)



Rank Relatedness score Related classes
1 0.0000034026 FOCAL ADHESION KINASE//INTEGRIN LINKED KINASE//FAK
2 0.0000025427 LAMININ//FIBRONECTIN//INVASION & METASTASIS
3 0.0000023462 GALLIUM NITRATE//GE 68 GA 68 GENERATOR//GALLIUM 68
4 0.0000017207 LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN
5 0.0000017085 E SELECTIN//SELECTIN//ICAM 1
6 0.0000014133 C 11RACLOPRIDE//FLUORINE 18//C 11FLB 457
7 0.0000010088 RHENIUMV//TECHNETIUM COMPLEXES//OXORHENIUMV
8 0.0000009626 GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO
9 0.0000009383 TIP30//LYMPHATIC SYSTEM MR//LYMPHOGRAPHY
10 0.0000009005 DCE MRI//CT PERFUSION//INTRAVOXEL INCOHERENT MOTION